Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lefkopoulou

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Lifetime Data Analysis|January 1, 1995
Intermediate clinical events, surrogate markers and survivalM Lefkopoulou, M Zelen
Biometrics|December 1, 1993
Global tests for multiple binary outcomesM Lefkopoulou, L Ryan
American Journal of Epidemiology|May 15, 1992
Methods for inference on transmission in seroprevalence data for multiple infectionsA A Evans, M Lefkopoulou, N E Mueller
Journal of the Air & Waste Management Association|December 1, 1991
Commuter exposures to VOCs in Boston, MassachusettsC C Chan, J D Spengler, H Ozkaynak, et al.
Hippokratia|February 6, 2023
The impact of the Covid-19 pandemic on a Greek cohort of patients with epilepsyE Giza, M Lefkopoulou, D Dimitrakopoulos, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Some considerations concerning the dose and schedule of 5FU and leucovorin: toxicities of two dose schedules from the intergroup colon adjuvant trial (INT-0089)D G Haller, M Lefkopoulou, J S Macdonald, et al.
Cancer|November 15, 1995
Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, M Lefkopoulou, et al.
American Journal of Clinical Oncology|December 1, 1988
ECOG phase II trials of MGBG, chlorozotocin, COM multidrug therapy in advanced measurable colorectal cancerH O Douglass, M Lefkopoulou, H L Davis, et al.
Controlled Clinical Trials|April 1, 1990
Issues in the design of drug trials for AIDSS B Green, S S Ellenberg, D Finkelstein, et al.
Journal of the National Cancer Institute|September 5, 1990
Quitting smoking in the United States in 1986E J Hatziandreu, J P Pierce, M Lefkopoulou, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Lifetime Data Analysis|January 1, 1995
Intermediate clinical events, surrogate markers and survivalM Lefkopoulou, M Zelen
Biometrics|December 1, 1993
Global tests for multiple binary outcomesM Lefkopoulou, L Ryan
American Journal of Epidemiology|May 15, 1992
Methods for inference on transmission in seroprevalence data for multiple infectionsA A Evans, M Lefkopoulou, N E Mueller
Journal of the Air & Waste Management Association|December 1, 1991
Commuter exposures to VOCs in Boston, MassachusettsC C Chan, J D Spengler, H Ozkaynak, et al.
Hippokratia|February 6, 2023
The impact of the Covid-19 pandemic on a Greek cohort of patients with epilepsyE Giza, M Lefkopoulou, D Dimitrakopoulos, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Some considerations concerning the dose and schedule of 5FU and leucovorin: toxicities of two dose schedules from the intergroup colon adjuvant trial (INT-0089)D G Haller, M Lefkopoulou, J S Macdonald, et al.
Cancer|November 15, 1995
Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, M Lefkopoulou, et al.
American Journal of Clinical Oncology|December 1, 1988
ECOG phase II trials of MGBG, chlorozotocin, COM multidrug therapy in advanced measurable colorectal cancerH O Douglass, M Lefkopoulou, H L Davis, et al.
Controlled Clinical Trials|April 1, 1990
Issues in the design of drug trials for AIDSS B Green, S S Ellenberg, D Finkelstein, et al.
Journal of the National Cancer Institute|September 5, 1990
Quitting smoking in the United States in 1986E J Hatziandreu, J P Pierce, M Lefkopoulou, et al.
Pageof 1